Biogen
$325.809876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$325.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.87 (-0.57%) Today
+$1.69 (+0.52%) As of 5:22 PM EST after-hours
Why Robinhood?
You can buy or sell Biogen and other stocks, options, ETFs, and crypto commission-free!
About BIIB
Biogen Inc. Common Stock, also called Biogen, is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Read More It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Employees
7,400
Headquarters
Cambridge, Massachusetts
Founded
1978
Market Cap
58.60B
Price-Earnings Ratio
10.72
Dividend Yield
—
Average Volume
1.69M
High Today
$330.59
Low Today
$322.83
Open Price
$327.20
Volume
1.83M
52 Week High
$374.99
52 Week Low
$215.78
Collections
Analyst Ratings
35%
of 31 ratings
Buy
35%
Hold
55%
Sell
10%
BIIB Earnings
$0.00
$3.06
$6.11
$9.17
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Available Apr 22, Pre-Market
People Also Bought
Bristol-Myers Squibb
7,782
$61.66
-3.61%Gilead Sciences
18,063
$70.33
-3.53%Bristol-Myers Squibb Comp...
$3.52
-3.55%AbbVie
27,048
$88.89
-4.56%Baidu
17,088
$124.43
-1.11%CVS
22,712
$64.47
-5.08%Amgen
2,372
$211.59
-2.89%Boeing
41,665
$304.14
-4.33%ViacomCBS
3,841
$25.36
-5.83%UnitedHealth
7,465
$263.39
-5.18%Kraft Foods
20,478
$26.07
-2.10%Regeneron
986